← Leaderboards
Jared William Young
University Of California, San Diego
$14,211,149
Attributed
$22,182,548
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,207,714 · 15
By mechanism
R01$18,423,355 · 7
UH3$2,050,332 · 2
R21$1,701,212 · 4
UH2$992,837 · 1
R13$39,978 · 1
Top collaborators
- William Perry8 shared
- Arpi Minassian7 shared
- Arthur Brody5 shared
- Ronald J. Ellis5 shared
- Adam L Halberstadt2 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Brook Henry$8,903,411
- Arpi Minassian$3,527,634
- Scott L Letendre$25,948,231
- Ronald J. Ellis$34,493,757
- Andre Der-Avakian$4,419,757
Others in their field
Top investigators on “Cognitive”
- David R. Weir · University Of Michigan At Ann Arbor$380,402,429
- Paul S. Aisen · Cognition Therapeutics, Inc.$185,453,129
- Randall J Bateman · Washington University$179,917,643
- Reisa A. Sperling · Banner Health$160,454,465
- Michael W Weiner · Northern California Institute Res &Educ$153,571,751
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$118,618,221
Research focus
CognitiveBehaviorBehavioralLinkBrainAffectCognitionAnimalsBaseBehavior TestRodentResponseChronicAnimal ModelDoseDopamineComplexRattusExhibitsMediatingAcuteReceptor ExpressionImpairmentDecision Making
Grant awards (49)
Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV$812,158
R01 · FY2025 · DA
Immunometabolicgene expression profiles associated with depressed mood and behavioral domains inpeople with HIV$696,003
R01 · FY2025 · MH
Optimization of the 5-choice continuous performance test to reveal a parietal-anterior cingulate-claustrum circuit underlying cognitive control and attention$335,750
R01 · FY2025 · MH · contact PI
Determining the efficacy of psychedelic agents reversing depression-relevant amotivated behaviors with concomittant EEG biomarkers.$197,500
R21 · FY2025 · MH · contact PI
Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV$812,158
R01 · FY2024 · DA
Immunometabolicgene expression profiles associated with depressed mood and behavioral domains inpeople with HIV$696,003
R01 · FY2024 · MH
Optimization of the 5-choice continuous performance test to reveal a parietal-anterior cingulate-claustrum circuit underlying cognitive control and attention$395,000
R01 · FY2024 · MH · contact PI
Determining the efficacy of psychedelic agents reversing depression-relevant amotivated behaviors with concomittant EEG biomarkers.$237,000
R21 · FY2024 · MH · contact PI
Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV$132,039
R01 · FY2024 · DA
Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV$812,158
R01 · FY2023 · DA
Immunometabolicgene expression profiles associated with depressed mood and behavioral domains inpeople with HIV$696,003
R01 · FY2023 · MH
Optimization of the 5-choice continuous performance test to reveal a parietal-anterior cingulate-claustrum circuit underlying cognitive control and attention$395,000
R01 · FY2023 · MH · contact PI
Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV$132,039
R01 · FY2023 · DA
Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV$812,158
R01 · FY2022 · DA
Immunometabolicgene expression profiles associated with depressed mood and behavioral domains inpeople with HIV$696,003
R01 · FY2022 · MH
Cannabis use and the endocannabinoid system in bipolar disorder$575,924
R01 · FY2022 · DA
Cannabis use and the endocannabinoid system in bipolar disorder$50,584
R01 · FY2022 · DA
Promoting Diversity, Inclusion, and Professional Development in the International Behavioral Neuroscience Society$19,978
R13 · FY2022 · MH · contact PI
Cross-species studies of smoking effects on cognition and neuroinflammation in HIV$884,326
R01 · FY2021 · DA · contact PI
Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV$811,729
R01 · FY2021 · DA
Immunometabolicgene expression profiles associated with depressed mood and behavioral domains inpeople with HIV$786,497
R01 · FY2021 · MH
Cannabis use and the endocannabinoid system in bipolar disorder$595,332
R01 · FY2021 · DA
Cannabis use and the endocannabinoid system in bipolar disorder$88,788
R01 · FY2021 · DA
Promoting Diversity, Inclusion, and Professional Development in the International Behavioral Neuroscience Society$20,000
R13 · FY2021 · MH · contact PI
Cross-species studies of smoking effects on cognition and neuroinflammation in HIV$860,394
R01 · FY2020 · DA · contact PI
Cannabis use and the endocannabinoid system in bipolar disorder$619,160
R01 · FY2020 · DA
Cannabis use and the endocannabinoid system in bipolar disorder$50,395
R01 · FY2020 · DA
Cross-species studies of smoking effects on cognition and neuroinflammation in HIV$860,394
R01 · FY2019 · DA · contact PI
Cannabis use and the endocannabinoid system in bipolar disorder$620,619
R01 · FY2019 · DA
ConProject-001$512,583
UH3 · FY2019 · MH · contact PI
Neurophysiological biomarkers of behavioral dimensions from cross-species paradigms$512,583
UH3 · FY2019 · MH · contact PI
Cross-species studies of smoking effects on cognition and neuroinflammation in HIV$860,394
R01 · FY2018 · DA · contact PI
Cannabis use and the endocannabinoid system in bipolar disorder$665,803
R01 · FY2018 · DA
Neurophysiological biomarkers of behavioral dimensions from cross-species paradigms$512,583
UH3 · FY2018 · MH · contact PI
ConProject-001$512,583
UH3 · FY2018 · MH · contact PI
Cross-species studies of smoking effects on cognition and neuroinflammation in HIV$881,238
R01 · FY2017 · DA · contact PI
Neurophysiological biomarkers of behavioral dimensions from cross-species paradigms$489,607
UH2 · FY2017 · MH · contact PI
A model organism of brain circuitry and behavioral switching for bipolar disorder$423,156
R01 · FY2017 · MH · contact PI
Oxytocin as a therapeutic target for Schizophrenia$74,682
R01 · FY2017 · MH · contact PI
Neurophysiological biomarkers of behavioral dimensions from cross-species paradigms$503,230
UH2 · FY2016 · MH · contact PI
A model organism of brain circuitry and behavioral switching for bipolar disorder$423,156
R01 · FY2016 · MH · contact PI
A model organism of brain circuitry and behavioral switching for bipolar disorder$423,156
R01 · FY2015 · MH · contact PI
Alpha 7 nicotinic receptor-mediated enhancement of reinforcement learning$193,750
R21 · FY2015 · MH · contact PI
A model organism of brain circuitry and behavioral switching for bipolar disorder$445,156
R01 · FY2014 · MH · contact PI
Alpha 7 nicotinic receptor-mediated enhancement of reinforcement learning$232,500
R21 · FY2014 · MH · contact PI
Visuospatial priming in rats: A novel animal model for Tourette Syndrome$191,194
R21 · FY2011 · MH · contact PI
Visuospatial priming in rats: A novel animal model for Tourette Syndrome$231,750
R21 · FY2010 · MH · contact PI
The rodent continuous performance task: Filling the vigilance translational gap$193,125
R21 · FY2010 · MH · contact PI
The rodent continuous performance task: Filling the vigilance translational gap$224,393
R21 · FY2009 · MH · contact PI